Adverse outcomes in relation to polypharmacy in robust and frail older hospital patients

Poudel, Arjun, Peel, Nancye M., Nissen, Lisa M., Mitchell, Charles A., Gray, Leonard C. and Hubbard, Ruth E. (2016) Adverse outcomes in relation to polypharmacy in robust and frail older hospital patients. Journal of the American Medical Directors Association, 17 8: 767.e9-767.e13. doi:10.1016/j.jamda.2016.05.017


Author Poudel, Arjun
Peel, Nancye M.
Nissen, Lisa M.
Mitchell, Charles A.
Gray, Leonard C.
Hubbard, Ruth E.
Title Adverse outcomes in relation to polypharmacy in robust and frail older hospital patients
Journal name Journal of the American Medical Directors Association   Check publisher's open access policy
ISSN 1538-9375
1525-8610
Publication date 2016-08-01
Year available 2016
Sub-type Article (original research)
DOI 10.1016/j.jamda.2016.05.017
Open Access Status Not yet assessed
Volume 17
Issue 8
Start page 767.e9
End page 767.e13
Total pages 5
Place of publication Philadelphia, PA, United States
Publisher Elsevier
Collection year 2017
Language eng
Formatted abstract
Objective: To explore the relationship between polypharmacy and adverse outcomes among older hospital inpatients stratified according to their frailty status.

Design and setting: A prospective study of 1418 patients, aged 70 and older, admitted to 11 hospitals across Australia.

Measurements: The interRAI Acute Care (AC) assessment tool was used for all data collection, including the derivation of a frailty index calculated using the deficit accumulation method. Polypharmacy was categorized into 3 groups based on the number of regular drugs prescribed. Recorded adverse health outcomes were falls, delirium, functional and cognitive decline, discharge to a higher level of care and in-hospital mortality.

Results: Patients had a mean (SD) age of 81 (6.8) years and 55% were women. Polypharmacy (5-9 drugs per day) was observed in 48.2% (n = 684) and hyper-polypharmacy (≥10 drugs) in 35.0% (n = 497). Severe cognitive impairment was significantly associated with nonpolypharmacy compared with polypharmacy and hyper-polypharmacy groups combined (P = .004). In total, 591 (42.5%) patients experienced at least 1 adverse outcome. The only adverse outcome associated with polypharmacy was delirium. Within each polypharmacy category, frailty was associated with adverse outcomes and the lowest overall incidence was among robust patients prescribed 10 or more drugs.

Conclusion: While polypharmacy may be a useful signal for medication review, in this study it was not an independent predictor of adverse outcomes for older inpatients. Assessing the frailty status of patients better appraised risk. Extensive de-prescribing in all older inpatients may not be an intervention that directly improves outcomes.
Keyword Adverse outcomes
Frailty
Older inpatients
Polypharmacy
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 11 Sep 2016, 10:19:22 EST by System User on behalf of Learning and Research Services (UQ Library)